Colon to Rectum

Scand J Gastroenterol. 2023;58(9):1085–90

Zhang Z, Chen X, Cao T, Ning Y, Wang H, Wang F, Zhao Q, Fang J

Polyps are detected more often in early colonoscopies


Objective: To examine the time variation in polyp detection for colonoscopies performed in a tertiary hospital and to explore independent factors that predict polyp detection rate (PDR).
Methods: Data on all patients who underwent colonoscopy for the diagnostic purpose at the endoscopy center in Zhongnan Hospital of Wuhan University from January 2021 to December 2021 were reviewed. The start time of included colonoscopies for eligible patients was recorded. PDR and polyps detected per colonoscopy (PPC) were calculated. The endoscopists’ schedules were classified into full-day and half-day shifts according to their participation in the morning and afternoon colonoscopies.
Results: Data on a total of 12,116 colonoscopies were analyzed, with a PDR of 38.03% for all the patients and 46.38% for patients ≥ 50 years. PDR and PPC significantly decreased as the day progressed (both p < 0.001). For patients ≥ 50 years, PDR declined below 40% at 13:00–13:59 and 16:00–16:59. The PDR in the morning was higher than that in the afternoon for both half-day (p = 0.019) and full-day procedures (p < 0.001). In multivariate analysis, start time, patient gender, age, conscious sedation, and bowel preparation quality significantly predicted PDR (p < 0.001).

Conclusions: The polyp detection declined as the day progressed. A continuous work schedule resulted in a subpar polyp detection rate (PDR). Colonoscopies performed in the morning had a higher PDR than that in the afternoon. Patient gender, age, conscious sedation, and bowel preparation quality were identified as the independent predictors of PDR.

J. Fang, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China, E-Mail: xhfangjun@163.com

DOI: 10.1080/00365521.2023.2202293

Back to overview

this could be of interest:

Preoperative treatment of locally advanced rectal cancer

N Engl J Med. 2023;389(4):322–34

Mercaptopurine for the treatment of ulcerative colitis: A randomized placebo-controlled trial

J Crohns Colitis. 2023;17(7):1055–65

More articles on the topic